Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-01T01:56:10.207Z Has data issue: false hasContentIssue false

Chapter 23 - Blood transfusion: preoperative considerations and complications

from Section 6 - Hematology

Published online by Cambridge University Press:  05 September 2013

By
Julie Katz Karp ,
Christopher D. Hillyer  and
Beth H. Shaz
Edited by
Michael F. Lubin ,
Thomas F. Dodson  and
Neil H. Winawer
Michael F. Lubin
Affiliation:
Emory University, Atlanta
Thomas F. Dodson
Affiliation:
Emory University, Atlanta
Neil H. Winawer
Affiliation:
Emory University, Atlanta
Get access

Summary

Introduction

In the USA, blood transfusion is the most common procedure performed in hospitals [1]. Component therapy is the preferred method of blood administration, as it allows blood transfusion to be individualized to the patient's specific needs. Blood components include red cells, platelets, plasma, and cryoprecipitate. Although transfusion is often essential to effective patient care, it is not without risk. Blood transfusion is associated with multiple adverse outcomes, including both non-infectious and infectious complications. Thus, benefits and risks of transfusion must be considered for each patient.

Maximum surgical blood order

A maximum surgical blood order schedule (MSBOS) is used to predict surgical blood needs and to reserve blood products for transfusion for surgery. A MSBOS is created by reviewing institutional blood utilization for each type of surgical procedure and usually set at the number of products required for 80–90% of the procedures. The MSBOS will dictate if either a type and screen (T/S) or a type and cross (T/C) is indicated, as well as the number and type of blood products to be reserved for a particular surgical procedure.

Type
Chapter
Information
Medical Management of the Surgical Patient
A Textbook of Perioperative Medicine
 , pp. 252 - 264
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agency for Healthcare Research and Quality, Overview of Hospitals. 2003. .
Roback, JD, Combs, MR, Grossman, BJ et al. AABB Technical Manual. 16th edn. Bethesda, MD: AABB; 2008.Google Scholar
Karen, E, King, MD, Gottschall, J et al. Blood Transfusion Therapy: A Physician’s Handbook. 9th edn. Bethesda, MD:AABB; 2008.Google Scholar
Hillyer, CD, Shaz, BH, Zimring, JC, Abshire, TC, eds. Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. Philadelphia, PA:Elsevier; 2009.
Blajchman, MA.The clinical benefits of the leukoreduction of blood products. J Trauma 2006; 60: s83–90.CrossRefGoogle ScholarPubMed
Nichols, WG, Price, TH, Gooley, T, Corey, L, Boeckh, M.Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003; 1010: 4195–220.CrossRefGoogle Scholar
Schroeder, ML.Transfusion-associated graft-versus-host disease. Br J Haematol 2002; 117: 275–87.CrossRefGoogle ScholarPubMed
Popovsky, MA.Frozen and washed red blood cells: new approaches and applications. Transfus Apher Sci 2001; 25: 193–4.CrossRefGoogle ScholarPubMed
Borgman, MA, Spinella, PC, Perkins, JG et al. The ratio of blood products transfused affects morality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 62: 805–13.CrossRefGoogle Scholar
The National Healthcare Safety Network (NHSN) Manual: Biovigilance Component. Centers for Disease Control and Prevention, June 2011. .
Zou, S, Stramer, SL, Notari, EP et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009; 49: 1609–20.CrossRefGoogle ScholarPubMed
Commanor, L, Holland, P.Hepatitis B virus blood screening: unfinished agendas. Vox Sanguinis 2006; 91: 1–123.CrossRefGoogle Scholar
Zou, S, Dorsey, KA, Notari, EP et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50: 1495–504.CrossRefGoogle Scholar
Dodd, RY, Notari, EP, Stramer, SL.Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975–9.CrossRefGoogle ScholarPubMed
US Food and Drug Administration. Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risks of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components intended for Transfusion. November 2009.
Centers for Disease Control and Prevention. West Nile Virus Transmission via Organ Transplantation and Blood Transfusion – Louisiana, 2008. Morbid Mortal Weekly Rep 2009; 58(45): 1263–7.Google Scholar
Perkins, HA, Busch, MP.Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010; 50: 2080–99.CrossRefGoogle ScholarPubMed
Young, C, Losikoff, P, Chawla, A, Glasser, L, Forman, E.Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007; 47: 540–4.CrossRefGoogle ScholarPubMed
AABB Association Bulletin #10–02 – Interim Standard 5.1.5.1.1. .
Benjamin, RJ, Kline, L, Dy, BA et al. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion 2008; 48(11): 2348–55.CrossRefGoogle ScholarPubMed
Eder, AF, Kennedy, JM, Dy, B et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004–6). Transfusion 2007; 47: 1134–42.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×